Systemic sclerosis: description and diagnostic role of the oral phenomena
Scardina, G.A.; Messina, P.
General Dentistry 52(1): 42-47
2004
ISSN/ISBN: 0363-6771 PMID: 15055670 Document Number: 578592
This study was designed to describe and evaluate the eventual prodromic role of the orofacial phenomena encountered in patients suffering from systemic sclerosis. Phenomena preceding the diagnosis and events that occured at the onset of systemic sclerosis were considered. Sclerodermic patients were monitored to implement a secondary preventive plan for controlling oral injuries caused by developing systemic sclerosis.
Document emailed within 1 workday
Related Documents
Uras, C.; Tabolli, S.; Giannantoni, P.; Rocco, G.; Abeni, D. 2014: The Italian version of the Systemic Sclerosis Questionnaire: a comparison of quality of life in patients with systemic sclerosis and with other connective tissue disorders Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 149(5): 539-548Seidenari, S.; Belletti, B.; Conti, A. 1996: A quantitative description of echographic images of sclerotic skin in patients with systemic sclerosis, as assessed by computerized image analysis on 20 MHz B-scan recordings Acta Dermato-Venereologica 76(5): 361-364
Parma-Benfenati, S.; Ferreira, P.A.; Fugazzotto, P.A.; Calura, G.; Berdichevsky, M.; Ruben, M.P. 1986: Progressive systemic sclerosis (scleroderma): oral-mucosal changes General Dentistry 34(2): 107-112
Sergiacomi, G.; De Nardo, D.; Capria, A.; Manenti, G.; Fabiano, S.; Borzi, M.; De Sanctis, G.; Konda, D.; Sperandio, M.; Schillaci, O.; Masala, S.; Simonetti, G.; Fontana, L. 2004: Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis In Vivo 18(2): 229-235
Sierakowska, M.; Sierakowski, S.ła.; Doroszkiewicz, H.; Lewko, J.; Jankowiak, B.; Kowalczuk, K.; Van Damme-Ostapowicz, K.; Krajewska-Kułak, E. 2011: Symptoms from the internal organs of patients with systemic sclerosis in the light of selected diagnostic tests Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 30(176): 116-120
Xu, D.; Barbour, M.; Jiang, H.-R.; Mu, R. 2019: Role of IL-33/ST2 signaling pathway in systemic sclerosis and other fibrotic diseases Clinical and Experimental Rheumatology 37 Suppl 119(4): 141-146
Ross, L.; Stevens, W.; Rabusa, C.; Wilson, M.; Ferdowsi, N.; Walker, J.; Sahhar, J.; Ngian, G.-S.; Zochling, J.; Roddy, J.; Tymms, K.; Major, G.; Strickland, G.; Proudman, S.M.; Nikpour, M. 2018: The role of inflammatory markers in assessment of disease activity in systemic sclerosis Clinical and Experimental Rheumatology 36 Suppl 113(4): 126-134
Frech, T.M.; Hudson, M. 2015: Protective role of interleukin-6 in systemic sclerosis gastrointestinal tract involvement: case report and review of the literature Clinical and Experimental Rheumatology 33(4 Suppl. 91): S179-S181
Kesselring, J. 1985: Paroxysmal phenomena in multiple sclerosis Schweizerische Medizinische Wochenschrift 115(30): 1054-1059
Bleistein, J.; Jerusalem, F. 1985: Paroxysmal phenomena in multiple sclerosis Der Nervenarzt 56(8): 440-441
Stepień, M.; Cendrowski, W. 1974: Form of systemic lupus erythematosus (lupoid sclerosis) resembling multiple sclerosis Neurologia i Neurochirurgia Polska 8(4): 607-609
Gawrysiak, W.; Skrypnik, K.; Suliburska, J.; Skrypnik, D.; Bogdański, Pł. 2017: Cardiac complications in rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis Przeglad Lekarski 74(4): 179-182
Obata, T.; Takahashi, H.; Nosho, K.; Ikeda, Y.; Tokuno, T.; Kawahito, Y.; Honda, S.; Makiguchi, Y.; Imai, K.; Ikeda, T. 1998: A case of systemic lupus erythematosus overlapping with progressive systemic sclerosis accompanied by deposition of AA amyloid in the stomach Ryumachi 38(6): 810-817
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Stachów, A.; Gliński, W.; Jarzabek-Chorzelska, M. 1976: Tryptophan metabolism in systemic scleroderma in comparison with immunological phenomena Przeglad Dermatologiczny 1976(6 Suppl): 357-361
Font, J.; Cervera, R.; Casals, F.J.; Bové, A.; Guerrero, A.; López-Soto, A.; Ingelmo, M.; Urbano-Márquez, A. 1988: Relation of antiphospholipid antibodies to thrombotic phenomena and clinical activity of systemic lupus erythematosus Medicina Clinica 90(12): 490-493
Matsumoto, T.; Kato, S. 2012: The concept of "elementary phenomena": a contribution to the diagnostic symptomatology of schizophrenia Seishin Shinkeigaku Zasshi 114(7): 751-763
Whicher, J.T.; Gilbert, A.M.; Westacott, C.; Hutton, C.; Dieppe, P.A. 1986: Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease Clinical and Experimental Immunology 65(1): 80-89
Kitaev, M.I.; Tsatskina, E.S. 1977: Increase in the diagnostic possibilities of certain cellular phenomena in drug allergy in tuberculosis patients Problemy Tuberkuleza 9: 43-48
Peruzzo, L.; Savio, S.; De Lalla, F. 1987: Systemic versus systemic plus oral chemoprophylaxis in elective colorectal surgery Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 6(2 Suppl): 601-603